STRAZZABOSCO, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 22.659
EU - Europa 9.358
AS - Asia 4.899
SA - Sud America 335
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 18
Totale 37.347
Nazione #
US - Stati Uniti d'America 22.277
SG - Singapore 1.907
CN - Cina 1.589
RU - Federazione Russa 1.572
SE - Svezia 1.510
IT - Italia 1.269
IE - Irlanda 1.240
DE - Germania 1.233
UA - Ucraina 1.117
HK - Hong Kong 797
GB - Regno Unito 525
CA - Canada 370
BR - Brasile 290
FI - Finlandia 287
FR - Francia 157
VN - Vietnam 143
IN - India 130
DK - Danimarca 103
AT - Austria 101
TR - Turchia 99
NL - Olanda 82
BE - Belgio 45
ID - Indonesia 37
JP - Giappone 35
EU - Europa 27
KR - Corea 26
BG - Bulgaria 23
IR - Iran 22
TW - Taiwan 21
ZA - Sudafrica 19
CZ - Repubblica Ceca 16
ES - Italia 16
AR - Argentina 14
BD - Bangladesh 12
CH - Svizzera 11
PK - Pakistan 11
AU - Australia 10
IQ - Iraq 10
RO - Romania 10
PH - Filippine 9
CO - Colombia 8
MX - Messico 8
MY - Malesia 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
CL - Cile 7
EC - Ecuador 7
MA - Marocco 7
PL - Polonia 7
UZ - Uzbekistan 7
MD - Moldavia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EG - Egitto 4
JO - Giordania 4
MM - Myanmar 4
PT - Portogallo 4
SC - Seychelles 4
AE - Emirati Arabi Uniti 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
TH - Thailandia 3
TN - Tunisia 3
VE - Venezuela 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
IL - Israele 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LT - Lituania 2
MU - Mauritius 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
A1 - Anonimo 1
BH - Bahrain 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
UY - Uruguay 1
Totale 37.347
Città #
Ann Arbor 3.259
Woodbridge 2.788
Fairfield 2.114
Houston 1.895
Chandler 1.334
Ashburn 1.243
Jacksonville 1.212
Dublin 1.204
Singapore 1.183
Wilmington 992
Seattle 870
Frankfurt am Main 807
Hong Kong 779
Cambridge 769
Dearborn 556
New York 552
Princeton 534
Santa Clara 393
Milan 382
Nanjing 290
Lawrence 228
Altamura 204
Lachine 197
Shanghai 178
Beijing 175
San Diego 128
Council Bluffs 116
Boardman 108
Guangzhou 88
Shenyang 82
Vienna 82
Andover 76
Nanchang 72
Toronto 69
Helsinki 68
Hebei 63
Ottawa 62
Moscow 60
Falls Church 57
Changsha 53
Hangzhou 52
Jiaxing 50
Tianjin 50
Norwalk 48
Dong Ket 47
Mountain View 45
London 44
Fremont 43
Philadelphia 41
Jinan 38
Los Angeles 37
Brussels 36
Huizen 36
Jakarta 35
Kunming 34
Nuremberg 32
Rome 32
Lissone 29
Redmond 29
Zhengzhou 29
Chicago 28
Pune 26
San Mateo 26
Ningbo 22
Auburn Hills 21
Plovdiv 20
Leawood 19
São Paulo 18
Taizhou 18
Boston 16
Padova 16
Tappahannock 16
Washington 16
Edmonton 15
Hefei 15
Nürnberg 15
Munich 14
Rio de Janeiro 14
Bologna 13
Fuzhou 13
Montréal 13
Bonndorf 12
Detroit 12
Kilburn 12
Dallas 11
Kiev 11
University Park 11
Belo Horizonte 10
Hounslow 10
New Haven 10
Brasília 9
Düsseldorf 9
Tokyo 9
Auckland 8
Brno 8
Dhaka 8
Kuala Lumpur 8
Lanzhou 8
Old Lyme 8
Wuhan 8
Totale 26.665
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 498
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 388
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 362
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 316
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 265
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 258
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 247
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 231
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 227
Long term outcome of acute pancreatitis in Italy: Results of a multicentre study 222
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 214
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 213
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 212
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 210
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 207
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 206
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 203
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 203
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 201
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 200
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 197
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice 196
Health Related Quality of Life in the Major Liver Conditions 195
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 194
Health related quality of life in chronic liver diseases 194
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 193
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 193
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 193
The impact of liver disease on the health-related quality of life 191
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 190
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 190
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 187
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 186
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 185
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 185
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 185
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 184
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 184
Effect of Silibinin on biliary lipid composition. Experimental and clinical study 183
Cholangiocyte biology as relevant to cystic liver diseases 182
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 182
Foxa1 and Foxa2 regulate bile duct development in mice 181
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 179
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 178
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 178
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 177
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 177
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 175
The challenges of primary biliary cholangitis: What is new and what needs to be done 175
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 174
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice 173
Liver-allocation policies for patients affected by HCC in Europe 172
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 172
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 171
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 171
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 171
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 170
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. 169
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 169
Vascular biology of the biliary epithelium 168
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 167
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 167
Intracellular alkalinization stimulates bile flow and vesicular-mediated exocytosis in IPRL 166
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 166
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 166
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 165
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 165
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 164
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 164
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 164
"The city of Hepar": Rituals, gastronomy, and politics at the origins of the modern names for the liver 163
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 163
The cholangiopathies: disorders of biliary epithelia 162
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 162
Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases 162
Notch signaling and new therapeutic options in liver disease 161
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 161
Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations 160
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 160
Regulation of activity and apical targeting of the Cl-/HCO3- exchanger in rat hepatocytes. 159
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice 159
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 159
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 159
Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines. 158
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 157
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 157
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 157
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 157
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 157
Functional anatomy of normal bile ducts 156
Intracellular pH regulation in isolated rat bile duct epithelial cells 155
Effect of UDCA on intracellular and biliary pH in isolated rat hepatocyte couplets and perfused livers 155
Emerging concepts in biliary repair and fibrosis 155
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 154
Proinflammatory cytokines inhibit secretion in rat bile duct epithelium 154
Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery 154
Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line 154
Altered store operated calcium entry increases cAMP production and ERK1/2 phosphorylation in Polycystin-2 defective cholangiocytes 154
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 153
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 153
Totale 18.736
Categoria #
all - tutte 138.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.087


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020809 0 0 0 0 0 0 0 0 0 288 400 121
2020/20214.303 369 357 442 453 331 269 378 313 380 434 274 303
2021/20222.877 130 293 499 219 101 210 133 197 143 199 244 509
2022/20235.338 594 1.602 470 404 435 810 72 278 369 31 178 95
2023/20243.783 151 142 112 179 505 1.038 764 139 333 33 24 363
2024/20255.992 551 1.073 423 324 775 275 522 405 757 887 0 0
Totale 38.350